Our Research Focus
Synthetic chemistry has the power to enable far-reaching investigations into human biology. Research in the Spiegel lab focuses on organic synthesis, with a specific emphasis on developing new methods and molecules that will facilitate our understanding and treatment of human disease. Ongoing projects range from synthetic reaction development and natural product synthesis to the construction of functional molecules capable of accomplishing specific biological tasks.
Announcements
Eugene's paper is accepted to JACS!
This publication provides a comprehensive mathematical framework for understanding ternary complex equilibria, previously believed to be analytically intractable. Find it here.
Congratulations to Samir and Phil on their recent review article in Trends in Biotechnology. The article highlights strategies to functionalize bacterial surfaces with small molecules and the applications of these strategies in biotechnology and biomedicine. Check it out!
David is awarded $3.6 million as a Department of Defense Era of Hope Scholar Award recipient. This will fund research for the development of a novel technology platform for developing personalized therapeutics for breast cancer. More about this exciting accomplishment can be found in the Yale News.
Congratulations to Phil Kim on the acceptance of his manuscript disclosing the unique reactivity of N-phenacyl-derived thiazolium salts toward alpha-dicarbonyl compounds. Check it out in Rejuvenation Research...well done, Phil!
SEPTEMBER 2012
Andrew Zhang becomes the inaugural Spiegel Group member to defend his thesis. Congratulations Dr. Zhang!
AUGUST 2012
See David's live UStream press conference on ARMs research during the Philadelphia National ACS Meeting. This research was also highlighted on About.com Pharma Guide.
JULY 2012
A big welcome to Mia Huang, the group's newest Postdoctoral Associate, who comes to us from Kent Kirshenbaum 's lab at NYU!
JULY 2012
The group's review on antibody-recruiting molecules is published in ACS Chemical Biology. Congratulations Pat, Chris, and Andrew!
JUNE 2012
David is the host of a Synthetic Immunology Ask the Expert forum on the ACS Chemical Biology community website. Post a question, thought, or comment here: Ask the Expert
APRIL 2012
The group reports their research into post-translational arginine modifications in JACS.
Congratulations to Tina and Prof. Rendy Kartika!
March, 2011
Watch David's Advanced Glycation End-products presentation at the SENS-5 Conference in Cambridge, England.
NOVEMBER, 2011
We proudly announce that David has been awarded a Novartis Early Career Award in Organic Chemistry for outstanding research within 10 years of starting his independent career. Congratulations, David! Read more about the Novartis Award.
NOVEMBER, 2011
The group reports an anti-cancer strategy utilizing antibody-recruiting molecules to target urokinase receptors. Congratulations to Chuck, Pat, and Andrew!
NOVEMBER, 2011
Congratulations to Chad Miller and Kelly Fitzgerald on passing their Pharmacology qualifying exams!
OCTOBER, 2011
We are pleased to welcome Postdoctoral Associate Cristian Draghici, who comes to us from the lab of Jon Njardarson at Arizona.
JULY, 2011
Congratulations to Chuck Jakobsche who was recently awarded a prestigious NIH Ruth Kirschstein postdoctoral fellowship through the National Cancer Institute.
May, 2011
The Spiegel Group welcomes newest members Samir Gautam, Chad Miller and Julian Vastl.
FEBRUARY, 2011
Congratulations to David for being named one of this year's recipients of the Alfred P. Sloan Foundation Research Fellowship!
Sloan Foundation, New Haven Register, NY Times
February, 2011
A highlight of the lab's work on antibody-recruiting molecules is published in the Yale Scientific Magazine. Congratulations!
JANUARY, 2011
The Spiegel Group is pleased to welcome newest group members, graduate students Nancy Tao and Kelly Fitzgerald, and laboratory associate, Dr. Takuji Shoda.
NOVEMBER, 2010
Congratulations to David for being selected as one of the winners of this year's Nature Chemical Biology Grand Challenges Essay Contest. His essay, entitled "Synthetic Immunology to engineer human immunity" is currently available online in the 5th anniversary issue of Nature Chemical Biology.
NOVEMBER, 2010
Our article in ACS Chemical Biology about re-engineering the Staphylococcus aureus cell wall with non-native small molecules has been highlighted in Cell, Biotechniques, R&D Magazine, Science Daily, Infection Research, e! Science News and Yale Daily News!
OCTOBER, 2010
Our strategy for biosynthetically incorporating small molecules into the Staphylococcus aureus cell wall is published in ACS Chemical Biology.
september, 2010
Our recent article about the discovery of a novel arene binding site on
prostate specific membrane antigen by ARM-Ps has been highlighted in C&E News
and Nature Chemical Biology!
august, 2010
The group reports investigations into antibody-recruiting small molecules targeting prostate cancer (ARM-Ps) in JACS. These studies describe the discovery of a novel arene binding site on prostate specific membrane antigen, the target of ARM-Ps. Congratulations Andrew!
June, 2010
Congratulations to group members Phil Kim and Eugene Douglass for passing their oral exams!
APRIL, 2010
The lab's work on antibody-recruiting molecules targeting prostate
cancer has been highlighted in ChemBioChem!
MARCH, 2010
Congratulations to Jason Gandelman, a senior at Staples High School, for being named one the 40 finalists in the Intel Science Talent Search! Jason has been working on a project related to the formation of advanced glycation end-products in the lab and has made great progress. Go Jason!
March, 2010
We are pleased to announce recent press coverage of antibody-recruiting small molecules targeting HIV and prostate cancer. This work has been highlighted in numerous publications and websites including Drug Discovery News, Popular Science, R&D Magazine, e! Science News, Science Daily, Genetic Engineering & Biotechnology News, and ACS Noteworthy Chemistry.
MARCH, 2010
The Spiegel Group is pleased to welcome their newest member, graduate student Tina Wang.
February, 2010
The lab's recent article involving antibody-recruiting small molecules targeting prostate cancer is reviewed as a "must read" paper on the Faculty of 1000, and is ranked among the top 10 "hidden jewels" and most read papers in the field of chemical biology. REVIEW
January, 2010
Recent Spiegel group publications on Antibody-Recruiting have been spotlighted in ACS Chemical Biology. Congratulations to Andrew, Chris, and Ryan! SPOTLIGHT
NOVEMBER, 2009
The group reports a novel strategy for recruiting endogenous antibodies to prostate cancer cells. Congratulations to Ryan and Andrew! JACS
OCTOBER, 2009
The group reports a novel small-molecule-based strategy for enhancing immune recognition of HIV. Congratulations to Chris Parker! JACS
SEPTEMBER, 2009
Welcome to new postdoctoral researcher Chuck Jakobsche, coming from Scott Miller's group at Yale, and visiting researcher Alex Chamessian from Stony Brook University.
APRIL, 2009
David Spiegel has received a Bill & Melinda Gates Foundation Grand Challenges Explorations award for innovation in global health research .
January, 2009
The Spiegel Group welcomes new graduate student group members Eugene Douglass, Taehan (Phil) Kim and Maria Noy.
OCTOBER, 2008
The Spiegel Group welcomes postdoctoral researcher Rendy Kartika, coming from
Richard E. Taylor's group at University of
Notre Dame.
SEPTEMBER, 2008
Congratulations David on being named one of this year’s recipients of the Ellison Medical Foundation New Scholar Award!
July, 2008
Welcome to postdoctoral researcher Mariya
Kolesnikova, who comes to us from Seiichi
Matsuda's group at Rice University.
September, 2007
David Spiegel was recently named one of the first recipients of the NIH Director’s New Innovator Award.
March, 2008
Welcome to new group members Chris Parker, Alison Wendlandt, Andrew Zhang, James Nelson, and Patrick McEnaney!
